While the signaling mechanisms of TLRs are well characterized, they do not completely account for the contrasting effects observed in prostate cancer, where activation of certain receptors such as TLR3 suppresses tumor growth, whereas others like TLR2 enhance it (Figure 2). This evidence concerns the gene TLR2 and Familial prostate cancer.